Colm O'Rourke

Colm O'Rourke is an Associate Professor at the University of Copenhagen's Faculty of Health and Medical Sciences, where he conducts research within the Andersen Group at the Biotech Research & Innovation Centre (BRIC). His work focuses primarily on gastrointestinal cancers, with special emphasis on biliary tract malignancies and liver cancers.

Dr. O'Rourke's research spans multiple critical areas in cancer biology:

• Molecular mechanisms of cholangiocarcinoma development and progression
• Epigenomic regulation, particularly DNA methylation patterns in cancer
• Genomic approaches to cancer risk assessment and classification
• Biomarker discovery for early detection and prognosis
• Novel therapeutic approaches including immunotherapy and targeted treatments
• Understanding mechanisms of treatment resistance in gastrointestinal cancers

His recent publication record demonstrates a strong focus on integrating genomic, epigenomic, and transcriptomic data to understand cancer biology. Dr. O'Rourke's work frequently addresses clinical translation, with multiple studies developing diagnostic signatures and validating prognostic tools that have direct implications for patient care in gastrointestinal oncology.

Notable contributions include:

• Genome-wide identification of hepatocellular carcinoma risk loci
• Investigations into the immunogenomic landscape of cholangiocarcinoma
• Development of DNA methylation-based diagnostic signatures
• Studies on protein SUMOylation as a therapeutic target
• Validation of prognostic gene scores for liver cancer patients

Dr. O'Rourke maintains an active collaborative network, as evidenced by his participation in numerous multi-center studies across international institutions. His laboratory at BRIC appears to focus on translating molecular discoveries into clinically applicable approaches for gastrointestinal cancer diagnosis and treatment.